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Ethnopharmacological relevance: The pharmacological activity of geopropolis collected by stingless bees
(important and threatened pollinators), a product widely used in folk medicine by several communities
in Brazil, especially in the Northeast Region, needs to be studied.
Objective: The aim of this study was to evaluate the antinociceptive activity of Melipona scutellaris
geopropolis (stingless bee) using different models of nociception.
Material and methods: The antinociceptive activity of the ethanolic extract of geopropolis (EEGP) and
fractions was evaluated using writhing induced by acetic acid, formalin test, carrageenan-induced
hypernociception, and quantiﬁcation of IL-1b and TNF-a. The chemical composition was assessed by
quantiﬁcation of total ﬂavonoids and phenolic compounds.
Results: EEGP and its hexane and aqueous fractions showed antinociceptive activity. Both EEGP and its
aqueous fraction presented activity in the mechanical inﬂammatory hypernociception induced by the
carrageenan model, an effect mediated by the inhibition of IL-1b and TNF-a. The chemical composition
of EEGP and its hexane and aqueous fractions showed a signiﬁcant presence of phenolic compounds
and absence of ﬂavonoids.
Conclusion: Our data indicate that geopropolis is a natural source of bioactive substances with
promising antinociceptive activity.
& 2012 Elsevier Ireland Ltd. Open access under the Elsevier OA license.1. Introduction
In recent decades, several researches have shown that analge-
sics represent one of the most studied therapeutic classes in the
world. This fact is understandable due to the high consumption of
these drugs worldwide, although it may present some adverse
effects and low therapeutic efﬁcacy. Thus, the effort to develop
new drugs have been the focus in the screenings of extracts from
natural sources, which historically have led to the discovery ofic fraction; EAF, ethyl acetate
, gallic acid equivalent;
indomethacin; morph,
crosis factor-alpha.
x: þ55 19 3421 0144.
osalen).
der the Elsevier OA license.many clinically important drugs in the current therapy (Verri
et al., 2006; Newman et al., 2003; Busnardo et al., 2010).
Propolis is a resin product collected by honey bees from
several parts of plants (Silva et al., 2008). For centuries propolis
has been used as a popular folk medicine, due to its biological and
pharmaceutical properties that include antiviral, anti-inﬂamma-
tory, analgesic, anticaries, antibacterial, antioxidant and anti-
cancer activities (Kujumgiev et al., 1999; Paulino et al., 2003;
Hu et al., 2005; Koo et al., 1999, 2000, 2002; Scazzocchio et al.,
2006; Kumazawa et al., 2007; Li et al., 2008). Although a multi-
tude of studies about propolis have been published, most of them
are from Apis mellifera. In contrast, reports about propolis from
other species of bees have been sparsely studied.
The bee species,Melipona scutellaris, which belongs to Meliponini
tribe (important and threatened pollinators) produces a variety of
propolis popularly known as geopropolis. This geopropolis consists
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chemical characteristics (Nates-Parra, 2001; Barth, 2006). However,
despite its popular use in folk medicine, very little is known about
its chemical composition and biological activity.
Among the few reports, Velikova et al. (2000) analyzed 21
samples of Brazilian geopropolis from 12 different species of
stingless bees, and observed the presence of compounds such as
di- and triterpenes and gallic acid. The same samples showed
activity against Staphylococcus aureus, and cytotoxic activity.
Another study reported that samples of Melipona fasciculata
geopropolis from Maranh~ao State showed activity against
Streptococcus mutans (Liberio et al., 2011). Bankova et al. (2000)
identiﬁed more than 50 substances, mainly phenolic compounds
in Brazilian geopropolis from Melipona compressipes, Melipona
quadrifasciata anthidioides and Tetragona clavipes. Previous inves-
tigations from our laboratory have found that geopropolis
from Melipona scutellaris has an antimicrobial action against
Staphylococcus aureus and antioxidant activity. These ﬁndings
suggested thatMelipona scutellaris geopropolis is highly bioactive,
deserving further studies to identify other possible biological
activities, as well as to elucidate its chemical composition, which
would ultimately strengthen its popular use.
Thus, the aim of this study was to evaluate the antinociceptive
activity of ethanolic extract of geopropolis (EEGP) of Melipona
scutellaris and fractions using the chemical models of abdominal
constrictions induced by acetic acid and formalin test. Moreover,
we evaluated the activity of the EEGP and bioactive fractions in
mechanical of inﬂammatory hypernociception model and the
production of IL-1b and TNF-a. Additionally we analyzed the
chemical composition of EEGP and bioactive fractions.2. Material and methods
2.1. Geopropolis samples and fractionation
The geopropolis samples were collected from the inner parts of
the beehives, more speciﬁcally in the space between the cover
and supers of hives. Geopropolis was collected between June and
July of 2010 in the seaside region, municipality of ‘Entre Rios’
(SL 11156’31’’ and WL 38105’04’’), state of Bahia, Northeast of
Brazil. The geopropolis (100 g) was extracted with absolute
ethanol (w/v) of proportion (1/7), at 70 1C, for 30 min, and then
ﬁltered to obtain the EEGP. The EEGP was further fractioned using
a liquid–liquid extraction technique with hexane, chloroform, and
ethyl acetate solvents. The ﬁnal residue obtained after ethyl
acetate fractionation was totally soluble in water, thus this ﬁnal
fraction was called aqueous fraction. The fractions obtained were
monitored by a thin layer chromatography (TLC) using the
anisaldehyde reagent (4-methoxy-benzaldehyde, acetic acid,
sulfuric acid/1.0:48.5:0.5) and followed by incubation at 100 1C
for 5 min. Fluorescent substances were visualized under UV light
at the wavelengths of 254 and 366 nm (Tanaka et al., 2005). The
EEGP and its hexane, chloroform, ethyl acetate, and aqueous
fractions were concentrated in a rotaevaporator at 40 1C to obtain
a yield of 4.33% (w/w), 1.98% (w/w), 0.23% (w/w), 0.87% (w/w),
and 1.25% (w/w), respectively. The EEGP and fractions were
dissolved in DMSO 1% (dissolved in PBS at 1 mM) for intraper-
itoneal (i.p.) administration.
2.2. Animals
Male SPF (speciﬁc-pathogen free) Balb/c mice weighing
20–25 g were housed in temperature (22–25 1C), 12 h light/12 h
dark and humidity (40–60%) with access to water and food
ad libitum. In the present study were used 6 mice (n¼6) perexperimental group. Experiments reported in this study were
carried out in accordance with current guidelines for the care of
laboratory animals and the ethical guidelines for investigation of
experimental pain in conscious animals (Zimmermann, 1983). All
efforts were made to minimize the number of animals used and
their suffering. The procedures described were reviewed and
approved by the local Animal Ethics Committee (CEUA Unicamp
process number 2037-1).
2.3. Drugs and reagents
The drugs were purchased from Sigmas Chemical Co., St.
Louis, MO, USA (Carrageenan), MP Biomedicalss (Indomethacin),
Mercks (Formaldehyde, Acetic acid and organic solvents) and
Crista´lias (Morphine).
2.4. Biological protocols
2.4.1. Evaluation of EEGP activity and fractions on abdominal
constriction responses caused by acetic acid
The abdominal constriction (writhes) were induced by i.p.
injection of acetic acid (1.2%) and carried out according to the
procedure described previously (Koster et al., 1959; Collier et al.,
1968). Mice were treated with EEGP, chloroform, ethyl acetate,
aqueous (1, 3, 10 and 30 mg/kg, i.p.) or hexane fractions (0.1, 0.3,
1 and 3 mg/kg, i.p.) 30 min before irritant injection. Indomethacin
(10 mg/kg, i.p.) was used as positive control and the vehicle was
used as the negative one. After the challenge, the mice were
individually placed in a glass cylinder of 22 cm diameter. The total
numbers of writhes, which consisted in the constriction of the
ﬂank muscles associated with inward movements of the hind limb
or with whole body stretching, were counted cumulatively in a
period of 20 min. The antinociceptive activity was determined as
the difference in number of writhes between control group and
each treated group.
2.4.2. Evaluation of EEGP activity and bioactive fractions on
formalin induced nociception
The method used in the present study was similar to that
described by Correˆa and Calixto (1993). The mice were treated
with EEGP, aqueous (1, 3, 10 and 30 mg/kg, i.p.) or hexane
fractions (0.1, 0.3, 1 and 3 mg/kg, i.p.) 30 min before injection
under the surface of the right hind paw of 25 mL 2.5% formalin
(0.92% formaldehyde) in saline. Indomethacin (10 mg/kg, i.p.)
and morphine (10 mg/kg, i.p.) were used as the positive control
and vehicle was used as the negative one. Animals were
observed from 0–5 min (neurogenic phase) and 15–30 min
(inﬂammatory phase) and the time spent licking the injected
paw was recorded with a chronometer and considered as
indicative of nociception.
2.4.3. Evaluation of EEGP activity and bioactive fractions on
carrageenan induced inﬂammatory hypernociception
Mechanical hypernociception was tested in mice as reported
by Cunha et al. (2004). The mice were treated with EEGP, aqueous
(1, 3, 10 and 30 mg/kg, i.p.) or hexane fractions (0.1, 0.3, 1 and
3 mg/kg, i.p.) 30 min before injection under the surface of the
left hind paw of 25 mL carrageenan (100 mg/paw). Indomethacin
(10 mg/kg, i.p.) was used as the positive control and vehicle was
used as the negative one. After the challenge, in a quiet room, the
mice were placed in acrylic cages (121017 cm3) with wire
grid ﬂoors (0.5 cm2), 15–30 min before the start of testing. The
test consisted of evoking a hind paw ﬂexion reﬂex with a hand
held force transducer (Insight Scientiﬁc Equipments, SP, Brazil)
adapted with a 0.5 mm2 polypropylene tip. The investigator was
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hind paw with a gradual increase in pressure. The end point was
characterized by the removal of the paw followed by clear
ﬂinching movements. After the paw withdrawal, the intensity of
the pressure was recorded automatically. The value for the
response was an averaging of 3 measurements. The animals were
tested before and after the treatments. The results are expressed
by delta (D) withdrawal threshold (in g) calculated by subtracting
the zero-time mean measurements (before carrageenan injection)
from the mean measurements 3 h after stimulus (after carragee-
nan injection).
2.4.3.1. Cytokine assays. Based on a previous test (2.4.3) the EEGP
and aqueous fraction were selected for the quantiﬁcation of
proinﬂammatory cytokines. The mice were treated with EEGP or
aqueous fraction (30 mg/kg, i.p.) 30 min before injection under the
surface of the left hind paw of 25 mL carrageenan (100 mg/paw).
Vehicle was used as the negative control. After 3 h, the animals were
killed, the plantar skin tissues were removed from the injected and
control paws (saline). The samples were homogenized in 500 ml
of the appropriate buffer containing protease inhibitors (Sigmas).
Levels of TNF-a and IL-1b, were determined by ELISA using
protocols supplied by the manufacturers (Peprotechs Inc.) from
both the experiments. The results are expressed as picograms.
2.4.4. Evaluation of EEGP activity and bioactive fractions in
locomotor activity
The open-ﬁeld test was used to exclude the possibility that the
antinociceptive action of EEGP, hexane and aqueous fractions could
be resultant from non-speciﬁc disturbances in the locomotor activity
of the animals. The ambulatory behavior was assessed in an open-
ﬁeld test as described previously Rodrigues et al. (2002) with
few changes. The apparatus consisted of a plastic box measuring
454520 cm3, with the ﬂoor divided into 9 equal squares
(1515 cm2). The number of squares crossed with all paws (cross-
ing) was counted in a 6 min session. The mice were treated with
EEGP (1, 3, 10 and 30 mg/kg, i.p.), hexane (1 and 3 mg/kg, i.p.) and
aqueous (10 and 30 mg/kg, i.p.) fractions or vehicle for 30 min. The
doses established in this test showed effect in the previous tests.
2.5. Chemical composition analysis of EEGP and bioactive fractions
2.5.1. Total polyphenol and ﬂavonoid
Total polyphenol content in EEGP, hexane and aqueous frac-
tions were determined by the Folin–Ciocalteau colorimetric
method (Singleton et al., 1999). EEGP or fractions (0.5 ml) were
mixed with 2.5 ml of the Folin–Ciocalteau reagent (1:10) and
2.0 ml of 4% Na2CO3. Absorbance was measured at 740 nm after a
2 h incubation at room temperature, in the dark. EEGP and its
fraction hexane and aqueous were evaluated at the ﬁnal concen-
tration of 90 mg/ml. Total polyphenol contents were expressed as
mg/g (gallic acid equivalents).
Total ﬂavonoid contents in the EEGP, hexane and aqueous
fractions were determined using a method described by Park et al.
(1995), with minor modiﬁcations. For this, 0.5 ml of EEGP, hexane
fraction, and aqueous solution, 4.3 ml of 80% ethanol, 0.1 ml of
10% Al(NO3)3 and 0.1 ml of 1 M potassium acetate was added.
After 40 min at room temperature, the absorbance was measured
at 415 nm. EEGP, hexane fraction and aqueous were evaluated at
the ﬁnal concentration of 2 mg/ml. Total ﬂavonoid contents were
calculated as quercetin (mg/g) from a calibration curve.
2.6. Statistical analysis
Original untransformed data are expressed as the mean7SEM
Statistical comparisons between groups were made usinganalyses of variance (ANOVA) followed by Tukey test (GraphPad
Prism for Windows, Version 5.0). Signiﬁcance was accepted when
the p value was r0.05.3. Results
3.1. EEGP, hexane and aqueous fractions decreased the number of
abdominal constrictions induced by acetic acid
The test of abdominal constrictions induced by acetic acid was
initially used to evaluate the antinociceptive activity of the EEGP
and their fractions. The results showed in Fig. 1A demonstrate
that the EEGP (3, 10 and 30 mg/kg), produced dose-related
inhibition of abdominal constrictions induced by acetic acid in
the mice (po0.05), with inhibitions of 31, 56 and 75% respec-
tively. The hexane fraction was able to inhibit the number of
writhes (po0.05) in 49 and 70% at doses of 1 and 3 mg/kg,
respectively (Fig. 1B), and the aqueous fraction inhibited
(po0.05) in 54 and 81% at doses of 10 and 30 mg/kg, respectively
(Fig. 1E). On the other hand, the chloroformic fraction (Fig. 1C)
and the ethyl acetate fraction (Fig. 1D), did not show any
inhibition (p40.05). Then the hexane and the aqueous fractions
were selected like the bioactive fractions from EEGP.
3.2. EEGP, hexane and aqueous fractions decreased nociception
induced by formalin
The results in Fig. 2A and B shows that the EEGP caused
signiﬁcant inhibition (po0.05) of both neurogenic (ﬁrst phase:
0–5 min) and inﬂammatory (second phase: 15–30 min) phases of
the formalin-induced licking. The calculated inhibition values for
these effects were 51 and 50% for the doses of 10 and 30 mg/kg,
respectively in the ﬁrst phase. In the second phase the EEGP
inhibited the response in 68, 52, 51 and 56% for the doses of 1, 3,
10 and 30 mg/kg, respectively. The hexane fraction showed activity
only in the ﬁrst phase (po0.05), with an inhibition of 65% at the
dose of 1 mg/kg (Fig. 2C). The aqueous fraction caused signiﬁcant
inhibition of both phases of the formalin-induced licking (po0.05),
with 59% at the dose of 10 mg/kg (phase 1), and 70 and 82% at the
doses of 10 and 30 mg/kg (phase 2), respectively (Fig. 2E and F).
3.3. EEGP and aqueous fractions decreased mechanical
inﬂammatory hypernociception by carrageenan
The effects of EEGP on hypernociception induced by carrageenan
are shown in Fig. 3A. EEGP at the tested doses of 10 and 30 mg/kg
showed an inhibition of 43 and 70%, respectively (po0.05). The
aqueous fraction showed an inhibition (po0.05) of 66% only at
30 mg/kg (Fig. 3C). On the other hand, the hexane fraction was not
effective even at the highest dose tested (Fig. 3B, p40.05).
3.3.1. Cytokine assay
The administration of EEGP and its aqueous fraction at a dose of
30 mg/kg, signiﬁcantly reduced (po0.05) the levels of IL-1b (77 and
89%, respectively) and TNF-a (41 and 48%, respectively), in mice
subjected to subplantar injection of carrageenan (Fig. 4A and B).
3.4. EEGP and bioactive fractions did not change the mice’s
locomotor activity
The administration of EEGP, hexane or aqueous fractions by
the i.p. route did not changed the locomotor activity of animals
during the 6 min of observation compared to the animals that
received vehicle (p40.05). The means7SEM crossed squared
were 3974 (control group), 4578; 2372; 37711 and 42711
Fig. 1. Effects of i.p. injections of ethanolic extract of geopropolis (EEGP) and fraction on abdominal constriction induced by acetic acid in mice. Control (C) treated with
vehicle, indomethacin 10 mg/kg (indo), EEGP (A), fractions: hexane (HF, B), choroformic (CF, C), ethyl acetate (EAF, D) and aqueous (AF, E). Data are expressed as
mean7SEM, n¼6. Symbols indicate statistical difference (po0.05, Tukey test). *po0.05 compared to control group.
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46719 for the hexane fraction (at 1 and 3 mg/kg, respectively)
and 2279 and 2377 for the aqueous fraction (at 10 and 30 mg/kg,
respectively).
3.5. Total polyphenol and ﬂavonoid contents of EEGP and bioactive
fractions
The mean7SD of the total phenols was estimated as
12771.9, 3870.7 and 13870.6 mg gallic acid equivalent/g of
sample for the EEGP, hexane and aqueous fractions, respectively
(Table 1). The presence of ﬂavonoids in any sample evaluated was
not observed.4. Discussion
The aim of this study was to evaluate the antinociceptive
activity of ethanolic extract of geopropolis (EEGP) from Melipona
scutellaris and fractions in different models of nociception, as well
as the mechanisms of the related action.
The ability of the EEGP as well as the hexane and aqueous
fractions demonstrated in the abdominal constrictions induced by
acetic acid in the mice suggests the ﬁrst sign of its antinociceptive
potential. The acetic acid induced constrictions test is described as a
typical model of inﬂammatory pain. It has long been used as a
screening tool for the assessment of the analgesic properties of new
drugs (Le Bars et al., 2001). The nociceptive response produced in
Fig. 3. Effects of i.p. injections of ethanolic extract of geopropolis (EEGP) and bioactive fraction on mechanical inﬂammatory hypernociception induced by carrageenan in
mice. Control (C) treated with vehicle, indomethacin 10 mg/kg (indo), EEGP (A), hexane fraction (HF, B) and aqueous fraction (AF, C). Data are expressed as mean7SEM,
n¼6. Symbols indicate statistical difference (po0.05, Tukey test). *po0.05 compared to control group.
Fig. 2. Effects of i.p. injections of ethanolic extract of geopropolis (EEGP) and its bioactive fractions on the formalin-induced nociception in mice. Control (C) treated with
vehicle, indomethacin 10 mg/kg (indo), morphine 10 mg/kg (morph), EEGP (A–B), hexane fraction (HF, C–D), and aqueous fraction (AF, E–F). Data are expressed as
mean7SEM, n¼6. Symbols indicate statistical difference (po0.05, Tukey test). *po0.05 compared to control group.
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such as prostaglandins, proinﬂammatory cytokines such as IL-1b, IL-
8, TNF-a, sympathomimetic amines, acetylcholine, and substance P,
among others (Kusuhara et al., 1997; Ribeiro et al., 2000; Duarte
et al., 1988; Le Bars et al., 2001). However, the test of abdominal
constrictions has low speciﬁcity, since several compounds, such as
antihistamines, neuroleptics and adrenergic blockers may also
inhibit constrictions (Le Bars et al., 2001). Thus we used the formalin
test, a chemical model of nociception, which provides a more
speciﬁc response compared with the model of abdominal constric-
tions induced by acetic acid (Tjolsen et al., 1992).
The injection of formalin produces a biphasic behavioral
response in which the ﬁrst phase (0–5 min) is characterized
by the occurrence of neurogenic pain by direct stimulation of
nociceptive afferent endings and the second phase (15–30 min) ischaracterized by peripheral inﬂammation and involves a period
of sensitization during which inﬂammatory phenomena occur
(Tjolsen et al., 1992). In this study, the EEGP and its aqueous
fraction showed antinociceptive activity in both phases neuro-
genic and inﬂammatory, while the hexane fraction showed
activity only in the neurogenic phase.
The effect of EEGP and its bioactive fractions was also eval-
uated in a model of mechanical inﬂammatory hypernociception
induced by carrageenan in mice and the production of IL-1b
and TNF-a. Carrageenan is an inﬂammatory agent that is largely
used as pharmacological tool for investigating inﬂammatory
hypernociception in rats and mice. When injected intraplantarly
in animal’s hind paw, it induces an inﬂammatory process asso-
ciated with hypernociception (Cunha et al., 2004). Tissue injury
originated after the injection of carrageenan involves the release of
Table 1
Quantiﬁcation of total phenols in EEGP, hexanic
and aqueous fractions by the Folin–Ciocalteau
method.
Sample mgGAE/g sample
EEGP 12771.9
Hexanic fraction 3870.7
Aqueous fraction 13870.6
Mean7SD, n¼03.
Total phenolic compounds expressed in mg gallic
acid equivalent (GAE)/g of sample.
Fig. 4. Quantiﬁcation of IL-1 b (A) and TNF-a (B) in the hind paw tissue of mice previously treated with vehicle (saline and carrageenan), ethanolic extract of geopropolis
(EEGP) and aqueous fraction (AF) at a dose of 30 mg/kg 30 min before the carrageenan intraplantar injection. Data are expressed as mean7SEM, n¼6. Symbols indicate
statistical difference (po0.05, Tukey test). #po0.05 compared to saline group; *po0.05 compared to carrageenan group.
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histamine and serotonin, neuropeptides, and proinﬂamatory cyto-
kines among others (Cunha et al., 1992; Ferreira et al., 1993).
Cytokines like IL-1b and TNF-a play a crucial role in the release of
prostanoids. This process occurs in the following sequence: TNF-a-
IL-1b-prostanoids which sensitize nociceptors (Cunha et al., 2005).
The release of proinﬂammatory cytokines IL-1b and TNF-a is also
directly related to the migration of neutrophils in the inﬂammatory
process, with induced rolling and adhesion of neutrophils in the
vascular endothelium, and transmigration into the inﬂammatory
site (Hogg and Walker, 1995). When neutrophils are present in
inﬂammatory focus, they release hypernociceptive mediators such
as prostaglandins (Cunha et al., 2008). In the present study, the
administration of EEGP and aqueous fraction reduced the inﬂam-
matory hypernociception which could be related with the inhibition
of IL-1b and TNF-a cytokines and consequent inhibition of the
release of prostanoids and also the interaction neutrophils and
endothelial cells. In the present study, we observed that the hexane
fraction did not decrease the mechanical inﬂammatory hypernoci-
ception, suggesting, therefore, another course of action independent
of the inﬂammatory process. The administration of EEGP and its
fractions did not cause any signiﬁcant change in the mice ambula-
tion during the open ﬁeld test, excluding non-speciﬁc disturbance in
the locomotor activity.
This study was also carried out by a phytochemical analysis of
EEGP and its bioactive fractions, by quantiﬁcation of total phenolics
and ﬂavonoids. Regarding the bioactive fractions, the presence
of phenolic compounds in both fractions (hexane and aqueous)
suggests the presence of these compounds with different polarities.
A higher concentration of phenolics was observed in the aqueous
fraction compared with the hexane fraction. The antinociceptiveactivity recorded for both fractions suggests that the effect detected
in the aqueous fraction may be related to this class of compounds
due to the higher concentration observed. However, the fact that the
phenolic content of the hexane fraction was lower than that
observed in the aqueous fraction does not exclude the hypothesis
that phenolic compounds may be responsible for this activity and
should be chemically investigated. In addition, the absence of
ﬂavonoids in the EEGP and its bioactive fractions, which is a very
common chemical class in Apis mellifera propolis (Kumazawa et al.,
2004; Alencar et al., 2007) was observed. The absence of ﬂavonoids
found in geopropolis was also been reported in Brazilian propolis
type 6 from Apis mellifera (Duarte et al., 2003). This particular Apis
mellifera propolis was also collected from the Atlantic forest in the
state of Bahia (Northeastern Brazil), which is not far away (about a
70 km radius) from where the geopropolis was collected for this
study. Since the geographical location and vegetation are related
with propolis chemical composition (Castro et al., 2007) it appears
reasonable to suggest that the vegetal resin originating the propolis
type 6 could have some similarity to that of the geopropolis.
Additionally, propolis type 6 has a group of polyprenylated benzo-
phenones whose biological activity was assigned to the substance
hiperibone A, a novel naturally occurring biomolecule (Castro et al.,
2009). These observations suggests that the geopropolis from Meli-
pona scutellarismay have an unusual chemical composition devoid of
signiﬁcant amounts of ﬂavonoids, instigating a better characteriza-
tion aiming the isolation/identiﬁcation of the bioactive compounds.
Therefore we conclude that the EEGP and its hexane and aqueous
fractions showed antinociceptive activity. The EEGP and aqueous
fraction demonstrated activity in the mechanical inﬂammatory
hypernociception induced by the carrageenan model, and this effect
is mediated by inhibition of IL-1b and TNF-a. The chemical composi-
tion of EEGP and its hexane and aqueous fractions showed a
signiﬁcant presence of phenolic compounds and absence of ﬂavo-
noids. This study could provide a scientiﬁc basis to its popular use in
the Brazilian folk medicine and suggests that more studies should be
conducted for the identiﬁcation and isolation of bioactive
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